Delivery Order SPE2DR25D9102-SPE2DR26FDDV6
Award Date 4/2/26
Potential Completion Date 4/23/26
Potential Value $5.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $13,220.34 delivery order to DMS Pharmaceutical Group Inc. on April 7, 2026, for YF-VAX 1 dose vials, with an ultimate completion date of April 28, 2026. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), the Defense Logistics Agency's single-award indefinite delivery contract for pharmaceutical products and medical consumables supporting Department of Defense healthcare operations worldwide. DMS...
- The Defense Logistics Agency issued a $1,888.62 delivery order to DMS Pharmaceutical Group Inc. on March 27, 2026, for YF-VAX 1 dose vials, with an ultimate completion date of April 17, 2026. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small...
- The Defense Logistics Agency issued a $1,888.62 delivery order to DMS Pharmaceutical Group Inc. on April 7, 2026, for YF-VAX 1 dose vials, with an ultimate completion date of April 28, 2026. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. This delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price calls for pharmaceutical...
- The Defense Logistics Agency issued a $1,888.62 delivery order to DMS Pharmaceutical Group Inc. on April 2, 2026, for YF-VAX 1 dose vials, with an ultimate completion date of April 23, 2026. DMS Pharmaceutical Group Inc. is a woman-owned small business. This delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract established to supply pharmaceutical products and medical consumables to...
- The Defense Logistics Agency issued a $1,888.62 delivery order to DMS Pharmaceutical Group Inc. on March 6, 2026, for YF-VAX 1 dose vials, with ultimate completion March 27, 2026. This order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business...
- The Defense Logistics Agency issued a $1,888.62 delivery order to DMS Pharmaceutical Group Inc. on March 4, 2026, for YF-VAX 1 dose vials, with an ultimate completion date of March 25, 2026. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency single-award indefinite delivery contract with a $499.9 billion ceiling supporting pharmaceutical supply to military healthcare facilities worldwide. DMS Pharmaceutical Group Inc....
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 20, 2026, for YF-VAX 1 dose vials with a ceiling value of $12,590.80. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract that authorizes firm fixed-price calls for pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities worldwide. DMS...
- The Defense Logistics Agency issued a $62,954 delivery order to DMS Pharmaceutical Group Inc. on March 16, 2026, for YF-VAX 1 dose vials, with an ultimate completion date of April 6, 2026. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price calls for pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities...
- The Defense Logistics Agency issued a $7,554.48 delivery order to DMS Pharmaceutical Group Inc. on March 30, 2026, for YF-VAX 1 dose vials under firm fixed-price terms. DMS Pharmaceutical Group Inc. is a woman-owned small business. The order was placed against the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract that authorizes firm fixed-price calls for pharmaceutical products and medical consumables to support...
- The Defense Logistics Agency issued a $1,888.62 delivery order to DMS Pharmaceutical Group Inc. on March 25, 2026, for YF-VAX 1 dose vials under a firm fixed-price arrangement, with ultimate completion on April 15, 2026. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, Illinois. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery...